Seer is a medical technology company on a mission to give people more control of their most valuable assets—their health and their time—by reimagining how and where they undergo long-term clinical monitoring. Seer's products and services are focused on solving the problems related to the early and accurate diagnosis of epilepsy. Seer’s flagship suite of technologies, offered through a provider partnership service called Seer Home, is an FDA-cleared Class II medical device that delivers a revolutionary home-based video-EEG-ECG monitoring solution for seizure disorders and related conditions. Seer Health, Seer’s division for long-term disease management, delivers the world’s first seizure risk forecaster through an app. Backed by groundbreaking research into seizure cycles, the Seer app uses self-reported event information to gain understanding of person's seizure cycles and generates a personalised outlook for seizure risk.